CURRICULUM VITAE

Name: Nathalie Scholler (née Buonavista), M.D., Ph.D.

Present Position: Tenure-track Assistant Professor, Department of Obstetrics and Gynecology.

Office: University of Pennsylvania School of Medicine.Center for Research on Reproduction and Women's Health Biomedical Research Building II/III, Room 1309 421 Curie Blvd., Philadelphia, PA, 19104-6160Phone: (215) 898 0164 – Fax: (215) 573 5129 - naths@mail.med.upenn.eduhttp://www.med.upenn.edu/crrwh/faculty/Scholler/Scholler.htmlhttp://www.med.upenn.edu/schollerlab/index.shtml  

Place of Birth: Marseille, France

Education:1995 PhD, Immunology University of Science of Aix-Marseille II, France1990 Diplôme d’études approfondies (equiv. MS) University of Science of Aix-Marseille II, France.

Immunology1988 MD, General Medicine School of Medicine, Marseille, France.

Training: 1995-1997 Post-Doctoral Fellowship Autoimmunity Department, Bristol Myers Squibb

Pharmaceutical Institute, Seattle, WA1991-1995 Scientific Fellowship Centre d’Immunologie de Marseille-Luminy,

University of Aix-Marseille II, France.

1986-1988 Intern in General Medicine University of Aix-Marseille Affiliated Hospitals, Marseille, France.

Additional Training:1993 Human genome analysis: from YAC to gene The 11th Welcome Summer School. United

Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, London, UK

2004 Engineering of Recombinant Antibodies Cambridge Healthtech Institute, Needham, MA

Faculty Appointments and Professional Positions: Nov. 2007-present Tenure-track Assistant Professor Department of Obstetrics and Gynecology,

University of Pennsylvania, Philadelphia, PA2003-2007 Senior Staff Scientist & Laboratory Director Translational and Outcomes Research laboratory,

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, WA.

2001-2003 Senior Research Scientist Department of Biochemistry, Seattle Genetics, Inc. Bothell, WA.

1997-2001 Staff Research Scientist Department of Tumor Immunology, Pacific Northwest Research Institute, Seattle, WA.

1990-1995 Physician - Sports Medicine French National Federation of Judo, Marseille, Fr.1989-1990 Physician Scientist French National Institute of Health and Medical

Research (INSERM), France and Brazil. 1988-1989 Resident in Internal Medicine Hôpital St Joseph, Marseille, France.

Page 1

Academic and Institutional committees2010-present Penn Institute for Immunology (Penn IFI), UPenn Member2010-present Bioengineering Graduate Studies, Bioengineering Graduate Group, UPenn Member2009-present Biomedical Graduate Studies, Immunology Graduate Group, UPenn Member 2008-present FOCUS Advisory Committee, UPenn Member2008-present Immunobiology program, Tumor Immunology Interest Group Full Research Member

Abramson Cancer Center, UPenn2007-present Penn Ovarian Cancer Research Center (Penn OCRC), UPenn Member

Memberships:2010-present New York Academy of Sciences (NYAS) 2010-present American Association for Cancer Research (AACR)2008-present Consortium for Functional Glycomics (CFG)2008-present Institute for Translational Medicine and Therapeutics (ITMAT) 2001-present American Association of Immunologists (AAI)2001-present American Association for the Advancement of Science (AAAS)2001-present American Society of Gene and Cell Therapy (ASGCT)

Scholarships, Fellowships and Awards:2011 Junior Faculty Travel Award

American Association of Immunologists (AAI 2011)

San Francisco, CA.2003-2004 Career Development Award Marsha Rivkin Center for Ovarian Cancer Research

(MRCOCR), Seattle, WA.2001-2003 Marsha Rivkin Center Scholar Award MRCOCR, Seattle, WA1995 Private fellowship La Fondation pour la Recherche Médicale, France.1991-1994 National scholarship French Ministry of Research & Technology, France. 1990 Private fellowship La Fondation pour la Recherche Médicale, France.1980-1986 Regional scholarship Province des Bouches-du-Rhône, France.

Organizing roles 2011 Host Break-out discussion at the 13th Annual Phage and Yeast Display of Antibodies & Proteins

conference, Protein Engineering Summit (PEGS) - May 9-10 - Boston, MA.2010 Moderator Center for Research on Reproduction and Women’s Health Annual Research Retreat and the

Cuozzo lecture- May 19- University of Pennsylvania, PA. 2010 Block Chair 97th AAI Annual meeting, Tumor Immune Response session - May 7-10 - Baltimore, MD 2009 Block Chair 96th AAI Annual meeting, Tumor Immune Escape - May 8-12 - Seattle, WA  2008 Block Chair 2nd International Conference on Ovarian Cancer: State of the Art and Future Directions - June 26 -

July 1- Rhodes, Greece

Scientific Review, Consulting and Advisory roles: 2011 Scientific reviewer for DOD Study section: Ovarian Cancer Research Program, Detection-

Diagnosis and Clinical and Experimental Therapeutic, DD-CET2011 Scientific expert for Wolf, Greenfield & Sacks, P.C., Boston, MA.2011 Scientific reviewer for Kentucky Science & Engineering Foundation.2010 Consultant for Reckner Healthcare.2010 Advisory Board Member in the Editorial Board of Recent Patents on Biomarkers.2010 Advisory Board member for the 2nd Annual Cancer Targets and Therapeutics Conference, Oct.

20-22, San Francisco.2010 Scientific reviewer for the Health Research Council (HRC), New Zealand.2010 Scientific reviewer for DOD Study section: Ovarian Cancer Clinical and Experimental

Therapeutics.2009-2011 Advisory Board tenured Member in the Editorial board of Journal of Proteome Research. 2009 Scientific reviewer for NIH Challenge grants in Health and Science Research (RC1).

Page 2

2009 Scientific reviewer for The Health Research Board, Ireland.2008 Scientific reviewer for Maryland Industrial Partnerships (MIPS).2008 Scientific reviewer for DOD Study section: Ovarian Cancer Research Program.2008 Consultant for Ernst & Young Life and Health Science Advisory, Paris, France.

Editorial Positions 2011-present Peer-Reviewer Disease markers.2011-present Peer-Reviewer OMICS: A Journal of Integrative Biology2011-present Peer-Reviewer Nature Communications.2011-present Peer-Reviewer Biomarkers in Medicine2011-present Peer-Reviewer Molecular Pharmaceutics.2011-present Peer-Reviewer Journal of Controlled Release.2010-present Peer-Reviewer Cancer Immunology Immunotherapy.2010-present Associate Editorial Board member Journal of Translational Research2010-present Peer-Reviewer Journal of Proteomics2009-present Peer-Reviewer Gynecologic Oncology2009-present Peer-Reviewer PlosONE2009-present Peer-Reviewer Clinical Science2009-present Peer-Reviewer Cancer Epidemiology2009-present Author-in-Chief Encyclopedia of Cancer, 2nd edition2006-present Peer-Reviewer Cancer Letters 2008-present Peer-Reviewer Cancer Biology & Therapy2008-present Peer-Reviewer Gynecologic and Obstetric Investigation 2008-present Peer-Reviewer Molecular and Cellular Proteomics

Presentations2011 Poster presentation “Development of T-bodies expressing CIR directed against Endosialin/TEM1 for immune-

gene therapy against breast cancer”. Nathalie Scholler, Stephen P. Santoro, Shree Joshi, Aizhi Zhao, and George Coukos, Era of Hope 2011, August 2-5, Orlando, FL.

2011 Invited speaker “Paired yeast-display/secretory vectors for rapid isolation of site-specific biotinylated affinity reagents”, 13th Annual Phage and Yeast Display of Antibodies & Proteins conference, Protein Engineering Summit (PEGS) - May 9-10 - Boston, MA.

2011 Oral presentation “Tumor released mesothelin contributes to the polarization of tumor-infiltrating macrophages”, 14th Annual Meeting of the Translational Research Cancer Centers Consortium conference, Seven Springs Mountain Resort - Feb 24-26 - Seven Springs, PA

2011 Invited speaker “GPI anchors: much more than an alternative strategy for cell surface presentation” GTCbio’s 3rd Oncology Biomarker Conference, Jan 27-28, San Diego, CA.

2011 Poster presentation “Tumor-infiltrating B-cells express toll-like receptors and exert proangiogenic activity in ovarian cancer”. S. Nunez-Cruz, W. Quinn, D. Connolly, P. Gimotty, and N. Scholler. EMBO 2011 meeting. Immunology & Metabolism- Centre d’Immunologie de Marseille-Luminy, January 13-14, Marseille, France.

2010 Invited speaker “Role of B cells in cancer development”. 23 rd Annual Immunology Retreat. November 5-7. Lancaster, PA

2010 Invited speaker “Novel mechanism for M2 polarization of tumor-infiltrating macrophages via GPI-anchored proteins”. Marsha Rivkin Center Ovarian Cancer Research Symposium, session: On the Horizon: Developing Therapeutics. Oct 28-29, Seattle, WA.

2010 Invited speaker “Tumor-infiltrating lymphocytes B (TIL-B) angiogenic properties contribute to tumor growth in presence of complement”. Department of Immunopathology, NIAID/NIH. June 3, Rockville, MD.

2010 Invited speaker “Study of the role of tumor-infiltrating B-cells in a transgenic mouse model of ovarian cancer”. Tumor Immunology Interest Group. May 20, University of Pennsylvania, PA.

2010 Poster presentation "Mannose receptor binding triggers M2-macrophage polarization" Denarda Dangaj, Selene Nunez-Cruz, Aizhi Zhao and Nathalie Scholler. Canary Foundation Early Detection Symposium, May 25-27, Stanford, CA

2009 Invited speaker “Alkali-resistant, site-specific biotinylated, high affinity reagent for IgG capture”. Bio-Rad laboratories, Dec. 9, Hercules, CA.

Page 3

2009 Invited speaker “Tumor-infiltrating B lymphocytes in ovarian cancer”. FCCC-UPENN Quarterly Ovarian Cancer Research meeting. Fox Chase Cancer Research Center, Dec. 3, Philadelphia PA.

Presentations (continue)2009 Invited speaker “Study of the role of CA125 and adipocytes in the alternative complement pathway during

ovarian cancer physiopathology” and “Blocking of CA125/Mesothelin-dependent peritoneal metastasis with antibodies and biobodies”. Fred Hutchinson Cancer Research Center, Scientific Program Committee Meeting. Nov 16, Seattle WA.

2009 Poster presentation "Blocking tumor/macrophages cross-talk with anti-mannose receptor recombinant antibodies to trigger tumor rejection" Denarda Dangaj, Aizhi Zhao, Raphael Sandaltzopoulos, George Coukos and Nathalie Scholler. 2009 NCI Translational Science Meeting (TSM 2), session: Therapeutic Antibodies and Combination Therapies, November 5-7, Vienna, VA.

2009 Poster presentation “Characterization of Tumor Infiltrating-B cells (TIL-B) in a transgenic mouse model of serous ovarian cancer.” Nunez-Cruz, S., Guerra, M., Queen, W., Scott P., Connolly, D., Cancro, M.P., Gimotty, P., and Scholler, N. Frontiers in Basic Immunology, NIH, October 1-2, Bethesda, MD.

2009 Invited speaker “Rapid identification of high affinity reagents using a yeast-expressed recombinant antibody platform”, Dana Farber/Harvard Medical School, June 19, Boston, MA.

2009 Invited speaker “Systèmes d’expression d’anticorps recombinants dans la levure: Application en Immunociblage”. INSERM -U 928- TAGC & UMR 928 Université de la Méditerranée, June 10, Marseille-Luminy, France.

2009 Invited speaker “Scouting glycoproteins in ovarian cancer”. CRRWH annual retreat, University of Pennsylvania, May 27, Philadelphia, PA.

2009 Invited speaker “Yeast-expressed recombinant antibody platform for rapid identification of high affinity reagents”. Institute of System Biology, May 11, Seattle, WA

2009 Invited speaker “Role of tumor-released GPI-anchor proteins in macrophage polarization”. Centocor, University of Pennsylvania, March 16, Philadelphia, PA

2009 Invited speaker “Biobody technology.” Drexel Institute for Biotechnology and Virology Research at Pennsylvania Biotechnology Center of Bucks County, March 11, Doylestown, PA.

2009 Invited speaker “Yeast-expressed recombinant antibody (scFv) for discovery of cancer biomarkers”, GlaxoSmithKline, March 10, King of Prussia, PA

2009 Invited speaker “Prevention of ovarian cancer peritoneal metastasis by designing blocking strategies of CA125/mesothelin interaction using natural or recombinant antibodies.” 6th Cancer Drugs R&D Conference. February 19-20, Philadelphia, PA.

2009 Invited speaker “The coming of age of ovarian cancer biomarkers.” 2nd Oncology Biomarkers Conference. Jan. 19-20, Miami, FL.

2008 Invited speaker “Using yeast for display and secretion of recombinant antibodies”, LifeSensors, Inc. October 28, Malvern, PA.

2008 Invited speaker “Selection of high affinity anti-TEM1 scFv by magnetic and flow sortings of a novel yeast-display scFv library”, Bracco Research USA Inc, September 25, Princeton, NJ.

2008 Invited speaker “Yeast-display scFv and biobodies”, Morphotek, Inc., July 14, Exton, PA.2008 Invited speaker “Generation of libraries of recombinant llama heavy-chain for diagnostic and discovery of

cancer markers”. Second International Conference on Ovarian Cancer: State of the Art and Future Directions, June 26 - July 1, Rhodes, Greece

2008 Poster presentation “Generation of recombinant libraries of heavy-chain V regions derived from Llama Glama”. Scholler N., Gross J.A. and Urban N. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA.

2007 Oral presentation “Development and in vitro Validation of anti-Mesothelin Biobodies that prevent CA125/Mesothelin-dependent Cell Attachment.”. Bergan L, Gross JA, Nevin B, Urban N and Scholler N. 15th SPORE Investigators’ Workshop Concurrent Poster Discussion Session:  New Technologies and Methodologies in Translational Research II, July 7-10, Baltimore, MA.

2007 Poster presentation “Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.” Scholler N, Bergan L, Gross JA, Garvik B,

Page 4

Nevin B, and Urban N. Federation of Clinical Immunology Societies (FOCIS) annual meeting, June 7-11, San Diego, CA.

Presentations (continue)2007 Poster presentation “Generation of a new type of yeast-secreted biotinylated recombinant antibodies directed

against mesothelin and able to prevent CA125/mesothelin-dependent cell attachment.”. Scholler N, Garvik B, Bergan L, Nevin B, Gross JA, and Urban N. ASGT 10th Annual Meeting, May 30 - June 3, Seattle, WA.

2007 Invited speaker “Design of new classes of recombinant antibodies and validation for use in cancer diagnostics and therapy.” University of Pennsylvania May 16, Philadelphia, PA.

2007 Poster presentation “Validation of in vivo-biotinylated yeast-secreted recombinant antibodies for use in diagnostic tests.” Scholler N, Lowe K, Bergan L, Kampani A, Gross JA, Garvik B and Urban N. - BioMarker World Congress 2007, May 15–17, Philadelphia, PA.

2006 Invited speaker “Utilisation d'un test d'adhésion cellulaire basé sur l'interaction CA125/mésotheline pour tester in vitro de nouvelles voies d'approches thérapeutiques pour la prévention de micro-métastases péritonéales du cancer de l'ovaire.” Institut de Cancérologie et d'Immunologie de Marseille IFR 137 (Institute of Cancer and Immunology) INSERM UMR 599, November 15, Marseille, France.

2006 Invited speaker “Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.” Laboratoire Technologies Avancées pour le Génome et la Clinique TAGC (Laboratory of Advanced Technology for Genome and Clinic) ERM 0206, November 14, Marseille –Luminy, France.

2006 Invited speaker “Generation of antigen-specific recombinant antibodies in the absence of purified and/or immunogenic antigens.” Seattle Biomedical Research Institute, November 6, Seattle, WA.

2006 Invited speaker “Generation of New Tools for Early Detection of Ovarian Cancer.” Complex Carbohydrate Research Center, University of Athens. September 29, Athens, Georgia.

2006 Oral presentation “Bead-Based ELISA Assays for Validation of Ovarian Cancer Early Detection Markers.” - Scholler N, Crawford M, Sato A, Drescher CW, O’Briant KC, Kiviat N, Anderson GL and Urban ND. Sixth Biennial Symposium sponsored by the MRCOCR, September 7-8, Seattle, WA.

2006 Oral presentation “Development of a CA125-Mesothelin Cell Adhesion Assay as a Screening Tool for Biologics Discovery.” Scholler N, Garvik B, Hayden-Ledbetter M, Kline T and Urban ND. Fourteenth SPORE Investigators’ Workshop Concurrent Plenary session, July 16-19, Baltimore MA.

2006 Poster presentation. “Biobodies: generation and validation.” Scholler, N. and Garvik, B. American Association of Immunologists, May 12–16, Boston, MA.

2005 Oral Presentation “Sandwich test ELISA with scFv antibodies: an alternative to an all-time favorite”- Scholler N, Garvik B and Urban N. Symposium of the Era of Hope Department of Defense Breast Cancer Research, Philadelphia, PA.

2004 Poster presentation “Generating New Tools for CD83 Functional Studies: Identification of an Anti-CD83 Recombinant Antibody that Binds to an HB15-Alternate Epitope” Hamel Y, Greenberg P and Scholler N. Twelfth International Congress of Immunology, Montreal, Canada.

2004 Oral presentation “Isolation of ovarian carcinoma-specific native proteins for development of new biomarkers.” Scholler N, Lampe P and Urban N. Eleventh SPORE Investigators Workshop, Baltimore, MD.

2002 Oral presentation “CD83 regulates the development of cellular immunity”. Scholler N, Hayden-Ledbetter M, Dahlin A, Hellström I, Hellström KE and Ledbetter JA. FASEB Immunology, New Orleans, LA.

2001 Oral presentation “CD83 is a adhesion receptor that binds monocytes and activated CD8+T cells” Scholler N, Disis ML, Dahlin A, Pullman J, Hellström KE and Hellström I. Eleventh International Congress of Immunology, Stockholm, Sweden.

2001 Oral presentation “HER2 DNA immunization with costimulatory molecules elicits functional anti-HER2 antibodies and CD4+ T cell tumor infiltration.” Scholler N, Ledbetter M., Hellström KE,

Page 5

Hellström I, Ledbetter JA - Eleventh International Congress of Immunology, Stockholm, Sweden.

Presentations (continue)2001 Oral presentation “HER2 DNA immunization with costimulatory molecules elicits functional anti-HER2

Antibodies.”. Scholler N, Disis ML, Dahlin A, Pullman J, Hellström KE and Hellström I - Fourth Annual Meeting of the ASGT, Seattle, WA. Abstract published in Molecular Therapy. 3(5): S69-70.

2001 Poster presentation “HER2 DNA immunization with costimulatory molecules”. Scholler N, Disis ML, Dahlin A, Pullman J, Hellström KE and Hellström I. Ninth SPORE Investigators Workshop, Washington, DC.

2000 Oral presentation “Antibodies to the HER2 protein can be elicited with DNA immunization.” Scholler N, Disis ML, Pullman J, Hellström KE and Hellström I - Third Biennial Ovarian Cancer Research Symposium, Seattle, WA.

1998 Oral presentation “DNA immunization with a combination of Rat Neu antigen, CD86 and 4-1BB ligand results in the generation of HER-2/neu (HER2) antibodies in Neu transgenic (neuT) mice.” Scholler N, Shiota FM, Pullman J, Hellström KE, Hellström I and Disis ML. Seventh International Conference on Gene Therapy of Cancer, Coronado, CA.

1994 Poster presentation “Mapping of CTLA4-CD28 genomic region by yeast artificial chromosomes (YAC).” Buonavista N, Balzano C, Pontarotti P, Le Paslier D and Goldstein P.- May 11-15, Workshop Genome mapping and sequencing, Cold Spring Harbor, NY.

1992 Invited speaker “Interest and advantage of YAC technology for genome mapping”- September 15, Workshop Pulse Field Electrophoresis, Pharmacia, France.

Abstracts2011 “Characterization of a TEM1 tumor-targeting antibody”. George Coukos, Aizhi Zhao, Chunsheng Li, Daniel

Ricklin, Tamara Seedial, and Nathalie Scholler, Era of Hope 2011, Orlando, FL.2011 “Developing magnetic nanoparticles for targeted nucleic acid delivery and detection” Poster presentation.

Prantner A.M., Chen J., Murray C.B., and Scholler N. ASGCT 2011, May7 17-21, Seattle, WA. 2011 “B cells infiltrating ovarian cancer exhibit a regulatory-like phenotype.” Selene Nunez-Cruz, William J. Quinn

III, Denise C. Connolly and Nathalie Scholler. Oral presentation, The Journal of Immunology, 2011 supplement, AAI 2011, May 13-17, San Francisco, CA. Travel Award, Selene Nunez-Cruz.

2011 “Mannose receptor regulates macrophage polarization in the tumor microenvironment” Denarda Dangaj, Shree Joshi, Aizhi Zhao, Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation, The Journal of Immunology, 2011 supplement, AAI 2011, May 13-17, San Francisco, CA.

2011 “Role of TLR engagement on TIL-B and clinical implications for ovarian cancer.” Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, Phyllis Gimotty and Nathalie Scholler. Poster presentation, AACR 2011, April 2-5, Orlando, FL.

2011 “Developing targeted superparamagnetic iron oxides for combination chemohyperthermia” Prantner A.M., Chen J., Murray C.B., and Scholler N. Poster presentation, Immunochemotherapy: Correcting Immune Escape in Cancer, March 10, Philadelphia, PA.

2011 “Modeling the human tumor-microenvironment in CD34 transplanted NSG mice” Marc Walter, Selene Nunez-Cruz, Ananda Mookerjee, Chongyun Fang, Andrea Facciabene, George Coukos, Gwenn Danet-Desnoyers and Nathalie Scholler. Poster presentation, Immunochemotherapy: Correcting Immune Escape in Cancer, March 10, Philadelphia, PA.

2011 “Reconstitution of the human ovarian tumor-microenvironment in CD34-transplanted NOD-Scid-IL2Rc null

(NSG) mice.” Marc Walter, Ananda Mookerjee, Selene Nunez-Cruz, Chongyun Fang, Andrea Facciabene, Daniel J. Powell Jr., George Coukos, Nathalie Scholler, and Gwenn Danet-Desnoyers. Poster presentation, TRC3 2011, February 24-26, Seven Springs, PA

2011 “Modulation of the tumor microenvironment by targeting the co-inhibitory B7H4 molecule”. Denarda Dangaj, Shree Joshi, Aizhi Zhao, Daniel J. Powell Jr., Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation, TRC3 2011, February 24-26, Seven Springs, PA

2010 “Characterization of scFv78: an anti-TEM1 scFv” Aizhi Zhao, Chunsheng Li, Daniel Ricklin, Tamara Seedial, George Coukos, Nathalie Scholler. International Society for Biological Therapy of Cancer (iSBTc). Poster presentation, October 2 - 4, Washington, D.C. The Journal of Immunotherapy, in press.

Page 6

2010 “Targeting of superparamagnetic iron oxide nanoparticles for cancer therapy based on localized hyperthermia” Andrew M. Prantner, Jun Chen, Christopher B. Murray and Nathalie Scholler. 6th annual Symposium Center for Translational Medicine, oral and poster presentations, June 4, Jefferson Medical College, Philadelphia, PA

Abstracts (continue)2010 “The binding of mannose receptor by tumor-released GPI-anchor proteins controls tumor-associated macrophage

phenotype”, Denarda Dangaj, Selene Nunez-Cruz, Aizhi Zhao, Raphael Sandaltzopoulos and Nathalie Scholler. Oral presentation, CRRWH annual retreat, University of Pennsylvania, PA. Presentation winner, D. Dangaj.

2010 “Gold nanorods conjugated to tumor-specific antibody for the targeting of ovarian cancer” Kolin C. Hribar, Gregory R. Wiedman, Andrew Prantner, Chaitanya Divgi, and Nathalie Scholler. Senior Design project of undergraduate students in Bioengineering, poster presentation, April 20, University of Pennsylvania, School of Engineering, PA.

2010 “Ovarian tumor infiltrating lymphocytes B (TIL-B) present pro-angiogenic properties.” Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, George Coukos, Phyllis Gimotty and Nathalie Scholler - The Journal of Immunology, 2010, 184, 101.7; AAI 2010, Poster and oral presentations. May 7-10, Baltimore, MD. Trainee Achievement Award, Selene Nunez-Cruz.

2010 “Comparative screening of human antibody libraries derived from autoimmune vs. cancer patients for affinity reagents directed against tumor-associated antigens”. Aizhi Zhao, Yi Cheng, George Coukos, Don Siegel, and Nathalie Scholler. - The Journal of Immunology, 2010, 184, 101.20 AAI 2010, Poster presentation. May 7-10, Baltimore, MD.

2010 “Tumor-released GPI-anchored proteins bind to mannose receptor and polarize tumor-infiltrating macrophages.” Denarda Dangaj, Aizhi Zhao, Selene Nunez-Cruz, Raphael Sandaltzopoulos and Nathalie Scholler - AACR 2010 Poster presentation. April 20, Washington, DC.

2010 “Genetic and pharmaceutical approaches for the study of complement factors as alternative therapy for ovarian cancer”. Selene Nunez-Cruz, Hongchang Qu, Stavros Rafail, Denise Connolly, Phyllis Gimotty, John Lambris, George Coukos, and Nathalie Scholler. - AACR 2010 Poster presentation. April 19, Washington, DC.

2010 “In vivo blocking of CA125/mesothelin-dependent cell adhesion prevents ovarian cancer peritoneal metastasis”. Denarda Dangaj, Amber Roberts, Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation.Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women's Cancer. March 14-17, San Francisco, CA.

2010 “MTB Hsp70-scFv Fusion and Self Assembling Proteins Targeting Mesothelin Control Tumor Growth and Augment Tumor Specific T Cell Responses In A Murine Model of Ovarian Cancer” Jianping Yuan, Pierre Leblanc, Elda Righi, Svetlana Korochkina, Jacalyn Rosenblatt, Brett Gotzbecker, Dimitris Tzachanis, Michael Santosuosso, Sandra Orsulic, Heidi Mills, Nathalie Scholler, David Avigan, Jeff Gelfand and Mark C. Poznansky. Poster presentation. Symposium Dana Farber/ Harvard Cancer Center ovca/ breast ca meeting. March 5, 2010, Boston, MA.

2010 “Ovarian tumor infiltrating lymphocytes B (TIL-B) are capable of synthesis and secretion of both pro- and anti-angiogenic factors.” Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, George Coukos, Phyllis Gimotty and Nathalie Scholler - Poster presentation, 13th Annual Meeting of the Translational Research Cancer Centers Consortium conference, The Ohio State University - March 1-2- Colombus, OH- First Price poster winner.

2010 “The binding of mannose receptor by tumor-released GPI-anchor proteins controls tumor-associated macrophage phenotype” Authors: Denarda Dangaj, Selene Nunez-Cruz, Aizhi Zhao, Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation. 13th Annual Meeting of the Translational Research Cancer Centers Consortium conference, The Ohio State University - March 1-2- Colombus, OH.

2009 “Development of a screening strategy to identify affinity reagents against formalin-fixed antigen”. Natalia Diaz-Rodriguez, Aizhi Zhao, Nathalie Scholler. Poster presentation. Short-term Elective Research (STER) Summer Student Symposium – September 11 – University of Pennsylvania, Philadelphia, PA.

2009 “Dual Specificity Suicide Gene Therapy Using Targeted Nanoparticles Directed against Ovarian Cancer”. Andrew M. Prantner, Patricia Ohana, Abraham Hochberg, Jerry D. Glickson, George Coukos and Nathalie Scholler. Poster presentation. Biomedical Post Doctoral Research Symposium 2009. University of Pennsylvania, Philadelphia, PA.

2009 “Tumor infiltrating-B cells (TIL-B) exhibit a regulatory phenotype in a transgenic mouse model of serous ovarian cancer”. Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, George Coukos, Phyllis Gimotty and Nathalie Scholler. Poster presentation. Biomedical Post Doctoral Research Symposium 2009. University of Pennsylvania, Philadelphia, PA.

Page 7

2009 “Development and validation of a ScFv specific for human glypican-3”. Yonghai Li, Aizhi Zhao, Hong Li, Oluwasayo Adeyemo, Nathalie Scholler, David Kaplan. Poster presentation. Department of Medicine Research Day - June 5 - University of Pennsylvania, Philadelphia, PA.

Abstracts (continue)2009 “Construction of a large scFv yeast display library and isolation of TEM1-specific antibodies of high affinity for

targeted-imaging and therapy of cancer” Zhao ., Li C., Nunez-Cruz S., Prantner A.M., Coukos G., Siegel D.L. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - Philadelphia, PA.

2009 “Rescue of anti-tumor macrophages using mannose-receptor targeted recombinant antibodies for ovarian cancer therapeutics” Dangaj D., Sandaltzopoulos R., Zhao A., Coukos G. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Developing a universal method to prepare scFv-modified nanoparticles for ovarian cancer diagnosis and therapy”. Prantner A.M., Glickson J.D., Coukos G. and Scholler N. Key note presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Development of an orthotopic mouse model of serous ovarian cancer for in vivo imaging” Nunez-Cruz S., Prantner A.M., Zhao A., Roberts A., Secreto A., Connolly D., Danet-Denoyers G., Coukos G. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Genetic Approach to Study Complement Role in Ovarian Cancer”. Nunez-Cruz S., Connolly D., Roberts A., Lambris J.D., Coukos G. and Scholler N. The Journal of Immunology, 2009, 182, 88.24; AAI 2009 - Poster or oral presentations. -May 8-12 - Seattle, WA. Travel Award, Selene Nunez-Cruz.

2009 “Identification of high affinity scFv antibodies against mouse and human tumor endothelial marker 1 (TEM1) using yeast-display scFv library derived from autoimmune patients”. Zhao, A, Li, C., Coukos C, Siegel D and Scholler N. The Journal of Immunology, 2010, 184, 101.20; AAI 2009- Poster or oral presentations. May 8-12 - Seattle, WA. Travel Award, Aizhi Zhao.

2009 “Genetic Approach to Study Complement Role in Ovarian Cancer”. Nunez-Cruz S., Connolly D., Roberts A., Lambris J.D., Coukos G. and Scholler N. Poster presentation. 12th Annual Meeting of the Translational Research Cancer Centers Consortium conference, University of Pennsylvania- March 6-7- Philadelphia, PA Third Price poster winner.

2009 “Blocking the chemical crosstalk between tumor cells and macrophages with recombinant antibodies to trigger tumor immune rejection.” Dangaj D, Sandaltzopoulos R, Coukos G and Scholler N. Poster presentation. 12th

Annual Meeting of Translational Research Cancer Centers Consortium conference, University of Pennsylvania- March 6-7- Philadelphia, PA

2009 “Development of a universal method for targeting nanoparticles with functionally intact scFv”. Prantner A.M., Glickson J.D., Coukos G and Scholler N. 12th Annual Meeting of the Translational Research Cancer Center s Consortium conference, Poster presentation University of Pennsylvania- March 6-7- Philadelphia, PA

2008 “In vivo Modeling and Detection of the Ovarian Cancer Vascular Marker TEM1”. Li C., Swails JC, Hasegawa K, O'Brien-Jenkins A, Liu Y, El-Deiry WS, Scholler N, Divgi C, Gimotty PA, Grasso L, Coukos G –Third International Conference on Molecular Diagnostics in Cancer Therapeutic Development , Poster and oral presentations. AACR - September 22, 2008- Philadelphia, PA. Award winner.

2008 “Novel Tumor Vascular Markers: Useful Biomarkers and Therapeutic Targets in Epithelial Ovarian Cancer”. Sasaroli D., Kougioumtzidou E., Hammond R., Buckanovich R.J., Sandaltzopoulos R., Scholler N., Gimotty P.A. and Coukos G. Poster presentation Second International Conference on Ovarian Cancer: State of the Art and Future Directions - June 26-July 1, 2008 - Rhodes, Greece

2008 “The Influence of Ovarian Cancer Risk-Status on the Diagnostic Performance of the Biomarkers Mesothelin, HE4 and CA125.” Shah C., Lowe K., Paley P., Wallace E., Anderson G., McIntosh M., Andersen R., Scholler N., Bergan L., Thorpe J., Urban N., Drescher C. Poster presentation Joint Meeting of the Western Association of Gynecologic Oncologists (WAGO) and the Felix Rutledge Society (FRS) - June 11-14, 2008 - Fairmont Sonoma Mission Inn, Sonoma, CA.

2008 “HE4 Bead-Based ELISA: Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies).” Forrest R., Scholler N., Lowe K., Bergan L., Kampani A., Thorpe J., Gross J., Garvik B. and Urban N. - Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA.

2008 “Use of cancer-specific in vivo-biotinylated recombinant antibodies (Biobodies) for serum biomarker discovery.” Scholler N., Gross J.A., Garvik B., Wells L., Liu Y., Loch C.M., Ramirez A.B., McIntosh M.W., Lampe P.D. and Urban N. Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA.

Page 8

2008 “Vascular Proteins Predict Clinical Outcome in Ovarian Cancer.” Sasaroli D., Gimotty P.A., Hammond R., Seedial T., Buckanovich R.J., Katsaros D., Scholler N. and Coukos G. Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA

2005 “Use of a yeast library of human antibody recognition sequences to develop diagnostic reagents.” Scholler N, Garvik B and Urban N. Poster presentation. XXII International Conference on Yeast Genetics and Molecular Biology, Bratislava, Slovakia.

Peer-reviewed research articles (*corresponding author)1. Buonavista, N ., Balzano, C., Pontarotti, P., Le Paslier, D. and Goldstein, P. 1992. Molecular linkage of human

CTLA-4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics. Jul; 13(3):856-861. 2. Balzano, C., Buonavista, N., Rouvier, E. and Goldstein, P. 1992. CTLA-4 CD28, similar protein, neighboring

genes. International Journal of Cancer. Suppl 7, 28-32. 3. Cornillon, S., Foa, C., Davoust, J., Buonavista, N., Gross, J. D. and Goldstein, P. 1994. Programmed cell death in

Dictyostelium. Journal of Cell Science. Oct; 107(10): 2691-2704. 4. Couissiner-Paris, P., Bourgeois, A., Dessein, H., Bacellar, O., Rodriguez, V. Jr., Kohlstadt, S., Buonavista, N.,

Pene, J. and Dessein, A. J. 1995. Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic of Schistosoma mansoni. European Journal of Immunology. 24 (4): 903-910.

5. Scholler, N ., Fu, N., Yang, Y., Ye, Z. M., Goodman, G. E., Hellström, K. E. and Hellström, I. 1999. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proceedings of the National Academy of Sciences of the United States of America . 96(20):11531-11536.

6. Hellström, I., Ledbetter, J. A., Scholler, N., Yang, Y., Ye, Z. M., Goodman, G. E., Pullman, J., Hayden-Ledbetter, M. and Hellström, K. E. 2001. CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer. Proceedings of the National Academy of Sciences of the United States of America . Jun 5; 98(12): 6783-6788.

7. *Scholler, N ., Hayden-Ledbetter, M., Hellström, I., Hellström, K. E. and Ledbetter, J. A. 2001. CD83 is a Sialic Acid-Binding Immunoglobin-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells. Journal of Immunology. 166: 3865-3872.

8. * Scholler, N., Hayden-Ledbetter, M., Dahlin, A., Hellström, I., Hellström, K. E. and Ledbetter, J. A. 2002. CD83 Regulates the Development of Cellular Immunity. Journal of Immunology. 168: 2599-2602.

9. Disis, M. L.+, Scholler, N.+, Dahlin, A., Pullman, J., Knutson, K. L., Hellström, K. E. and Hellström, I. 2003. Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity. Molecular Cancer Therapy. Oct; 2(10):995-1002.(+these authors equally contributed to the work).

10. McIntosh, M. W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellström, I. and Hellström, K. E. 2004. Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecologic Oncology. 95(1):9-15.

11. *Scholler, N ., Crawford, M., Sato, A., Drescher, C. W., O’Briant, K. C., Kiviat, N., Anderson, G. L. and Urban, N. Bead-based ELISA assays for validation of ovarian cancer early detection markers. Clinical Cancer Research. 2006. 12: 2117-2124.

12. *Scholler, N., Garvik, B., Quarles, T., Jiang, S. and Urban, N. 2006. Method for generation of in vivo biotinylated recombinant antibodies by yeast mating. Journal of Immunological Methods. Dec 20; 317(1-2):132-143. Epub 2006 Oct 30.

13. *Scholler, N., Garvik, B., Hayden-Ledbetter, M., Kline, T. and Urban, N. 2007. Development of a CA125-Mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer Letters. Mar 8; 247(1):130-136. Epub 2006 May 4.

14. Bergan, L., Gross, J. A., Nevin, B., Urban, N., and *Scholler, N. 2007. Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment. Cancer Letters. Oct 8; 255(2):263-74. Epub 2007 Jun 7.

15. Loch, C. M., Ramirez, A. B., Liu, Y., Sather, C. L., Delrow, J.J., Garvik, B., Scholler, N., Urban, N., McIntosh, M. W. and Lampe, P. D. Use of High Density Antibody Arrays to Validate and Discover Cancer Serum Biomarkers. Molecular Oncology. Volume 1, Issue 3, December 2007, Pages 313-320

16. * Scholler, N., Lowe, K. A., Bergan, L. A., Kampani, A. V., Ng, V., Forrest, R. M., Thorpe, J. D., Gross, J. A., Garvik, B. M., Drapkin, R., Anderson, G. L. and Urban, N. Use of yeast-secreted in vivo biotinylated recombinant antibodies (biobodies) in bead–based ELISA. Clinical Cancer Research. 2008 May 1:14(9):2647-55

Page 9

17. Faca, V., Song, K., Wang, H., Zhang, Q., Krasnoselsky, A., Ireton, R., Newcomb, L., Plentz, R., Glukhova, V., Phanstiel, D., Gurumurthy, S., Redston, M. S., Brenner, D., Anderson, M., Misek, D., Scholler, N., Urban, N., Barnett, M., Edelstein, C., Goodman, G., Thornquist, M., McIntosh, M., DePinho, R. A., Bardeesy, N. and Hanash S. Markers for human pancreatic cancer based on plasma proteome analysis of a mouse model. PLoS Med. 2008 Jun 10;5(6):e123.

18. Palmer C., Duan X., Hawley S., Scholler N ., Thorpe J., Sahota R., Wong M., Wray A., Drescher C., McIntosh M., Brown P., Nelson B., Urban N. Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer. PLoS ONE - 2008 Jul 9;3(7):e2633.

19. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer. 2008 Jun 25. Jun 25;113(3):484-489. DOI: 10.1002/cncr.23577

20. *Scholler N. , Gross JA., Garvik B., Wells L., Liu Y., Loch CM., Ramirez AB., McIntosh MW., Lampe PD., Urban N. Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery. Journal of Translational Medicine. 2008, 6:41

21. Lowe K., Shah C., Wallace E., Anderson G., Paley P., McIntosh M., Andersen R., Scholler N., Bergan L., Thorpe J., Urban N., Drescher C. Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Post-menopausal Women at High-Risk for Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention. 2008 Sep;17(9):2480-7.

22. C. Shah, K. Lowe, P. Paley, E. Wallace, G. Anderson, M. McIntosh, R. Andersen, N. Scholler, L. Bergan, J. Thorpe, N. Urban, C. Drescher. “Influence of ovarian cancer Risk status on the Diagnostic Performance of the serum Biomarkers Mesothelin. HE4 and CA125”.-Cancer Epidemiology Biomarkers & Prevention (CEBC) Prev. 2009 May;18(5):1365-72

23. Gonzalez, J.M., Ofori E., Burd I., Chai J., Scholler N., Elovitz M.A.: “Maternal mortality from systemic illness: unraveling the contribution of the immune response”. Am J Obstet Gynecol 2009, 200, 430 e1-8.

24. Chen, A., Kozak, D., Battersby, B.J., Forrest, R.M., Scholler, N., Urban, N., and Trau, M. “Antifouling Surface Layers for Improved Signal-to-Noise of Particle-Based Immunoassays” –Langmuir. 2009, 25 (23), pp 13510–13515

25. Anderson G.L., McIntosh M.,Wu L., Thorpe J.D., Bergan L., Goodman G., Barnett M., Thornquist M.D., Scholler N., Kim N., O’Briant K., Drescher C., Urban N.. “Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case-Control Study” –JNCI. 2010 Vol. 102, Issue 1, January 6.

26. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P and Urban N. “Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.” -Gynecol Oncol. 2010 Mar;116(3):378-83. Epub 2009 Nov 28.

27. Aizhi Zhao, Selene Nunez-Cruz, Chunsheng Li, George Coukos, Don L. Siegel and *Nathalie Scholler. “Rapid isolation of high affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast display/secretory scFv library platform.” JIM, Jan 5; 363(2):221-32. Epub 2010 Sep 15.

28. Selene Nunez-Cruz, Denise C. Connolly and Nathalie Scholler. “An orthotopic model of serous ovarian cancer in immunocompetent mice for in vivo tumor imaging and monitoring of tumor immune responses.” JoVE , 2010 Nov 28. (45), pii:2146, doi:10.3791/2146. [Epub ahead of print]

29. Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila). 2011 Mar;4(3):375-83.

30. Cramer DW, Bast RC Jr, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011 Mar;4(3):365-74.

31. Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biol Ther. 2011 Aug 1;12(3). [Epub ahead of print] PubMed PMID: 21617380

32. Nicole Urban, Jason D. Thorpe, Martin McIntosh, Lindsay Bergan, Robin Forrest, Archana Kampani, Nathalie Scholler, Kathy O’Briant, Charles Drescher, Dan Cramer, Chris Berg. "Potential role of HE4 in multimodal screening for epithelial ovarian cancer" In press, JNCI brief communication.

Page 10

Submitted peer-reviewed research articles.Denarda Dangaj, Karen Abbott, Ananda Mookerjee, Aizhi Zhao, Pamela S. Kirby, Raphael Sandaltzopoulos, Daniel J.

Powell Jr., Antonin Lamazière, Don L. Siegel, Claude Wolf, and *Nathalie Scholler. “Mannose receptor engagement by mesothelin GPI anchor polarizes tumor associated macrophages and is blocked by a recombinant antibody directed against mannose receptor domain 4.” PLosOne Accepted pending revisions.

Selene Nunez-Cruz, Phyllis Gimotty, Matthew Guerra, Denise Connolly, Daniel J. Powell Jr., Robert DeAngelis, John D. Lambris, George Coukos and *Nathalie Scholler. "Ovarian Cancer Development Requires Complement Factor 3 and is Facilitated by Proangiogenic Tumor Infiltrating B-Cells". Submitted JEM

Evripidis Lanitis, Mathilde Poussin, Ian Hagemann, Raphael Sandaltzopoulos, Nathalie Scholler, and Daniel J. Powell, Jr. “Redirected anti-tumor activity of primary human lymphocytes transduced with a fully-human anti-mesothelin chimeric receptor”. Submitted

Eleftheria Kalogera; Nathalie Scholler; Cecelia Powless; Amy Weave; Ronny Drapkin; Jinping Li; Shi-Wen Jiang; Karl Podratz; Nicole Urban; Sean Dowdy. “Correlation of Serum HE4 with Tumor Size and Myometrial Invasion in Endometrial Cancer”. Submitted

Reviews *Scholler, N. and Urban N. CA125 in Ovarian Cancer. Biomarkers in Medicine 1(4), December 2007, Pages 513-523. *Scholler, N., Mesothelin, Encyclopedia of Cancer, 2nd edition, 1836-1940 (2008)*Scholler, N.,2nd Oncology Biomarkers Conference (Miami, FL), Thomson Reuters Scientific division (2009)*Scholler, N.6th Cancer Drugs R&D Conference (Philadelphia, PA), , Thomson Reuters Scientific division (2009)*Scholler N., “Oncology Biomarkers. the Investigational Drugs journal 2009 12(4): © Thomson Reuters (Scientific) Ltd

ISSN 2040-3410Sasaroli D., Coukos G. and *Scholler N. “Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there

yet?” - Biomarkers in Medicine. Prev. 2009 May;18(5):1365-72Tanyi J.L and *Scholler N. “From the endometrium physiology to a comprehensive strategy for the discovery of ovarian

cancer biomarkers.” Oncology reviews. 2010 March, Vol. 4, Number 1, pages 43-50. *Scholler, N, 3rd Oncology Biomarkers Conference (San Diego, CA), Thomson Reuters Scientific division. (2011)Tanyi, J.L. and *Scholler, N. “Oncology Biomarkers for Detection and Therapeutic Monitoring of Gynecologic

Malignancies”. Frontiers in Biosciences. In press

Book Chapters *Scholler, N. "Selection of antibody fragments by yeast display" chapter of “Antibody Engineering: methods and

protocols" section in the lab-protocol based 'Methods in Molecular Biology' series, Humana Press editors. (in press)

Mantia-Smaldone, G.M. and *Scholler, N. "Ovarian Cancer" chapter of InTech book project, Open Access publisher. ISBN: 978-953-307-812-0. (in press)

Editorial*Scholler, N. Novel targeting strategies using recombinant antibodies for early diagnosis and therapy of ovarian cancer.

Future Medicine Therapy. 2010, 7(3), 209-212

Patents

Page 11

1. Scholler N. and Garvik B., US Patent No. 7,795,411 (“Methods of Generation of in vivo biotinylated recombinant antibodies”).

2. Law CL, Pestano LA, Wahl AF, and Scholler N, US Patent No. 7,662,387 (“Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders”).

3. Law CL, Pestano LA, Wahl AF, and Scholler N, US Patent Application No. 12/467,182 (“Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders”).

4. Law CL, Pestano LA, Wahl AF, and Scholler N, US Patent Application No. 12/635,571 (“Treatment of B-cell cancers with anti-CD70 antibody drug conjugates”).

5. Law CL, Pestano LA, Wahl AF, and Scholler N, US Patent Application No. 12/635,607 (“Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates”).

6. Scholler N, Disis ML, Hellström I, and Hellström KE, US Patent No. 6,734,172 (“Surface receptor antigen vaccines”).

7. Ledbetter JA, Scholler N, Hayden-Ledbetter M, Hellström I, and Hellström KE, US Patent Application No. 10/098,221 (“Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein”).

8. Ledbetter JA, Scholler N, Hayden-Ledbetter M, Hellström I, and Hellström KE, US Patent Application No. 11/600,927 (“Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein”).

9. Scholler N, Hellström I, and Hellström KE, US Patent No. 6,770,445 (“Methods and compositions for diagnosing carcinomas”).

10. Scholler N, Hellström I, and Hellström KE, US Patent No. 7,745,159 (“Methods and compositions for diagnosing carcinomas”).

11. Scholler N, Hellström I, and Hellström KE, US Patent Application No. 12/781,231 (“Methods and compositions for diagnosing carcinomas”).

12. Scholler N, Zhao, Siegel DL, and Coukos G, International Patent Application No. PCT/US10/56477 (“Anti-TEM1 antibodies and uses thereof”).

Page 12

Mentoring and teaching activitiesReceived Training2008 The Art of Speaking: Professional Communication for Faculty 2008 Effective Abstract Writing 2008 The Art of Award Winning Poster Presentations 2010 Overview of Education at Penn Medicine Workshop 2010 Writing Letters of Recommendation for Trainees2010 Interactive Teaching2011 Effective Lecturing

Administrative Teaching Activities

Dates Position/title Organization Location Frequency Total hrs/yr

Since 2008

IGG Recruitment committee member

Biomedical Graduate Group (IGG) Penn School of Medicine

Annual 4

Since 2010

Judge and mentor Annual AACR Undergraduate Student Caucus and Poster Competition.

AACR meetings

Annual 8

06/02/2010

Facilitator Responsible Conduct in Research (RCR) workshop

Penn School of Medicine

Once 2

04/06/2011

Mentor AACR, Special Program for High School Students

AACR meetings

Once 2

05/19/2011

Committee member for Rafael Winograd

Biomedical Graduate Group, Cancer Biology. Thesis Preliminary exam.

Penn School of Medicine

Once 4

07/18/2011

Committee member for Ajlan Al Zaki

Bioengineering Graduate Group, Cellular and Molecular Imaging. Thesis Preliminary exam.

Penn School of Bioengineering

Once 4

Teaching

Date Teaching type Title Location Type and number of students

Frequency

Total hrs/yr

2007 Workshop Recombinant antibodies

Fred Hutchinson CRC, Seattle, WA

30 Post-doc. fellows

Once 2

2008 Lecture Yeast-display scFv Cold Spring Harbor, NJ

40 Post-doc. fellows

Once 2

2009 Lecture Introduction to innate and adaptive immune systems & inflammation

Biostatistic Graduate Group, Upenn.

7 PhD students Once 2

2009 Directed reading (Imm 520)

Role of B cells in solid tumor

Biomedical Graduate Group, Upenn.

1 PhD student Natalie Steinel

Once 10

2010 Lecture(CBE 564)

Targeted therapies Bioengineering Graduate Group, Upenn,

21 graduate students

Once 1

Since 2010Lecture (Imm 599)

Immunology Faculty Research Seminar

Biomedical Graduate Group, Upenn.

~15 PhD students

Annual

0.5

Page 13

2010 Lab rotation (Imm 699)

Yeast-display scFv screening

School of Medicine,UPenn.

1 graduate studentNicole Martinez

Once 12

2010 Course(CAMB 701)

Tumor microenvironment

Biomedical Graduate Group, Upenn.

9 PhD students Once 30

2011 Course(Imm 508)

Humoral responses in cancer

Biomedical Graduate Group, Upenn.

4 PhD students Once 36

2011 Lab rotation(CAMB 699)

Mannose receptor polymorphism

Biomedical Graduate Group, Upenn.

1 graduate studentMichael Allegrezza

Once 12

Trainees

Graduate students    Date Position in my lab Name Publications, abstracts and awards Current position

2008-present PhD Student/ visitor scientist(PENN lab)

Denarda Dangaj Publications:PlosOne submitted, 1st authorAbstracts & Awards:AAI 2011, JI supplementBest presentation CRRWH 2010 

PhD Student/visitor scientist in my lab

Post-doctoral fellows    2005-2006 Post-doctoral Fellow

(FHCRC lab)Sanjiban Barnejee Founder of

AbGenics, National Chemical Laboratory, Pune, India

2008-2009 Post-doctoral Fellow(PENN lab)

Selene Nunez-Cruz

Publications:JIM 2010, 2nd author.JoVE 2010, 1st author.J Exp Med in prep, 1st author.Abstracts & Awards:AAI 2009, Travel Award, JI suppl.AAI 2010, Trainee Achievement award, JI suppl.AAI 2011, Travel Award, JI suppl.Third price poster presentation TRC3 2009First price poster presentation TRC3 2010

Research associate in my lab since April 2010.

2008-2010 Post-doctoral Fellow (PENN lab)

Aizhi Zhao Publications:JIM 2010, 1st author.J Exp Med in prep., 4th author.Abstracts & Awards:AAI 2009, Travel Award, JI suppl.

Research associate since November 2010 (Coukos lab, OCRC).

2008-present Post-doctoral Fellow (PENN lab)

Andrew Prantner Abstracts & Awards:Keynote speaker, CRRWH

Post-doctoral Fellow in my lab.

2010-2011 Post-doctoral Fellow(PENN lab)

Ananda Mookerjee Publication: PlosOne, submitted, 3rd author

Post-doctoral Fellow (Coukos lab, OCRC)

Page 14

Mentoring

2011 Summer Internship Norma A. Brown Undergrad. in Bioengineering, Penn School of Engineering2010-11 Elizabeth Blackwell Society Katie Manning First year Medical school student, Penn School of Medicine2010-11 Senior Design Project Andrew Lee Undergrad. in Bioengineering, Penn School of Engineering2010-11 Senior Design Project Kevin Chu Undergrad. in Bioengineering, Penn School of Engineering2010-11 Senior Design Project Matt Cha Undergrad. in Bioengineering, Penn School of Engineering2010-11 Senior Design Project Xiao Ling Undergrad. in Bioengineering, Penn School of Engineering2010 Summer Internship Ashley Jordan Undergraduate in Biochemistry, Special Programs

Biomedical Graduate Studies, UPenn, PA.2009-10 Elizabeth Blackwell Society Charlotte Lawson First year Medical school student, Penn School of Medicine2009-10 Senior Design Project Kolin Hribar Undergrad. in Bioengineering, Penn School of Engineering.

Now a graduate student at UC, San Diego, CA.2009-10 Senior Design Project Gregory Wiedman Undergrad. in Bioengineering, Penn School of Engineering.

Now a graduate student at John Hopkins, Baltimore, MA.2009 Independent work study Tamara Seedial Masters in Biotechnology, Penn School of Engineering.2009 Independent work study Natalia

Diaz-RodriguezNIH-funded Short Term Training, PhD student, University of Pennsylvania.

2008 Visitor scientist Murielle Saade Graduate student, University of Aix- Marseille II, FranceNow a post-doctoral fellow in Barcelona, Spain.

Page 15

ovarian cancer vaccines.

Page 16